All Insiders Activity for RAPT Therapeutics Inc. (RAPT)

$ 18.10   0.25 (+1.40%) Volume: 42.95k 3:25 PM EDT 29-May-2020
Name: Transaction:
Date Name: Shares Transaction Value
05/15/20 Dirk G. Brockstedt,
Chief Scientific Officer
9,877 Option Exercise at $6.18 per share. $61,040
05/15/20 Dirk G. Brockstedt,
Chief Scientific Officer
9,877 Sell at $15.00 per share. $148,155
05/12/20 Karen C. Lam,
VP, Finance & Controller
2,777 Option Exercise at $1.86 per share. $5,165
05/07/20 Karen C. Lam,
VP, Finance & Controller
1,831 Sell at $15.40 per share. $28,197
01/30/20 Brian Russell Wong,
Director, President and CEO
22,000 Acqusition at $0.00 per share. $0
01/30/20 Karen C. Lam,
VP, Finance & Controller
2,500 Acqusition at $0.00 per share. $0
01/30/20 Dirk G. Brockstedt,
Chief Scientific Officer
8,000 Acqusition at $0.00 per share. $0
12/03/19 Wendye Robbins,
22 Buy at $23.07 per share. $508
12/02/19 Wendye Robbins,
200 Buy at $21.87 per share. $4,374
11/27/19 Wendye Robbins,
78 Buy at $26.60 per share. $2,075
11/04/19 David V. Goeddel,
Director, Ten Percent Owner
1,166,666 Conversion at $0.00 per share. $0
11/04/19 David V. Goeddel,
Director, Ten Percent Owner
727,008 Conversion at $0.00 per share. $0
11/04/19 David V. Goeddel,
Director, Ten Percent Owner
625,000 Buy at $12.00 per share. $7,500,000
11/04/19 David V. Goeddel,
Director, Ten Percent Owner
1,454,016 Conversion at $0.00 per share. $0
11/04/19 David V. Goeddel,
Director, Ten Percent Owner
145,401 Conversion at $0.00 per share. $0
  Page 1 of 2   Next Page
View Section 16 Filings (Forms 3,4,5) for RAPT Insider Summary For RAPT